Two Sigma Investments’s Passage Bio PASG Stock Holding History
Bought
Maintained
Sold
Other funds holding PASG
LCM
VPC
EAM
NLVP
TCM
O
Two Sigma Investments's PASG Position: Q3 2025 in Review
Two Sigma Investments sold out of Passage Bio (PASG) in Q3 2025, closing a stake of 2,358 shares — an estimated $18.9K sold.
Two Sigma Investments first reported a position in PASG in Q1 2021 and held it in 18 quarters. The position peaked at $2.72M in Q4 2021. 32 funds tracked by Wall St. Rank hold PASG as of Q3 2025.
- Two Sigma Investments reported no remaining Passage Bio position as of Q3 2025 after selling out during the quarter.
- Two Sigma Investments sold 2,358 Passage Bio shares in Q3 2025, an estimated $18.9K.
- Two Sigma Investments first reported a position in Passage Bio in Q1 2021 and held it in 18 quarters.
- Two Sigma Investments's Passage Bio position peaked at $2.72M in Q4 2021.
- 32 funds tracked by Wall St. Rank held Passage Bio as of Q3 2025.
Based on Two Sigma Investments's 13F filing for Q3 2025, filed 14 Nov 2025.